FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Guide on Device Bench Test Reports

Federal Register notice: FDA makes available a draft guide entitled Recommended Content and Format of Complete Test Reports for Non-Clinical Bench Per...

Federal Register

Guide on Drug-related Blood Pressure Effects

Federal Register notice: FDA makes available a draft guidance entitled Assessment of Pressor Effects of Drugs.

Medical Devices

Branchpoint Wireless Intracranial Pressure Sensor Cleared

FDA clears a Branchpoint Technologies 510(k) for its Aura ICP Monitoring System, an implantable and wireless intracranial pressure sensor.

Federal Register

ICH Guide on Q12 Post-approval Drug Changes

Federal Register notice: FDA makes available a guidance entitled Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Mana...

Human Drugs

Allergan Recalls 1 Lot of Mispackaged Contraceptives

Allergan recalls one lot of oral contraceptive Taytulla (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) 1mg/20mcg...

Human Drugs

FDA Steps to Reduce REMS Generic Drug Blocks

FDA issues two draft guidances to help prevent branded drug companies from using shared system REMS negotiations to block generic entry.

Human Drugs

FDA Wants More Drug Shortage Info

FDA commissioner Scott Gottlieb says the agency is looking for additional steps it can take to mitigate the effect of drug shortages and help prevent ...

Medical Devices

MicroVention PMA Approved for Aneurysm Device

FDA approves a MicroVention PMA for the LVIS and LVIS Jr. stents for stent-assisted coil embolization of intracranial aneurysms.

Human Drugs

Nektar NDA for Pain Drug with Reduced Euphoria

Nektar Therapeutics files an NDA for NKTR-181, an analgesic opioid molecule that the company says exhibits a reduced incidence of specific side effect...

Human Drugs

Draft Guide on ICH Q12 Drug Manufacturing Annex

FDA makes available an International Council for Harmonization draft guidance entitled Q12 Technical and Regulatory Considerations for Pharmaceutical ...